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Background. There are limited data on the impact of the imaging protocol (single-day
stress-rest, SD, vs. dual-day, DD) on the change in left ventricular (LV) ejection fraction (EF)
(post-stress-rest) in relation to ischemia and on outcome.
Methods. Using propensity score matching procedure, 490 of 1121 patients with known
CAD, undergoing a SD or a DD in a multicenter study, were evaluated. Stress and rest gated-
SPECT myocardial perfusion imaging was used to quantify LV perfusion, EF, and volumes.
Outcome was assessed at an average follow-up time of 3.2 years.
Results. Post-stress LVEF in SD and DD were comparable across all degrees of ischemia.
The change in LVEF in patients with severe ischemia was, however, higher in the DD protocol,
independent of the extent of CAD. At follow-up, 240 patients (49.0%) required coronary
revascularization (CR) and 52 patients (10.6%) had hard events. The ischemic burden was
independently associated with CR and hard-events; the post-stress LVEF was associated with
CR but the change in EF was not predictive of either CR or hard events.
Conclusions. In patients with severe ischemia, underestimation of post-stress myocardial
stunning could be observed with the SD protocol. Post-stress LVEF and the extent ischemia, but
not the change in EF, are predictive of CR and hard events. (J Nucl Cardiol 2016)
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Abbreviations
CAD Coronary artery disease
CR Coronary revascularization
DD Dual-day
EF Ejection fraction
EDV End-diastolic volume
ESV End-systolic volume
LV Left ventricular
MPI Myocardial perfusion imaging
SD Single-day
SDS Summed difference score
SRS Summed rest score
SSS Summed stress score
See relatededitorial, doi: 10.1007/s12350-
016-0473-8.
INTRODUCTION
Gated-SPECT myocardial perfusion imaging (MPI)
provides incremental diagnostic and prognostic infor-
mation in patients with known or suspected coronary
artery disease (CAD).1–5 The use of 99mTc-labeled
tracers, due to their intra-cellular trapping, requires two
separate tracer injections for a complete stress/rest
study; this can be obtained using a single-day (SD) or
dual-day (DD) protocols.6 The time interval between
tracer injection during stress and image acquisition, the
type of stressor used (exercise vs vasodilator stress), and
the study protocol could affect the relationship between
ischemia and left ventricular (LV) ejection fraction (EF)
and conceivably outcome prediction.7–9
The aim of this study was to examine the differen-
tial impact of these variables on myocardial perfusion
and LV EF and volumes using a propensity matching
analysis of a large cohort of patients enrolled in a
multicenter study in whom coronary angiographic data
were also available.
METHODS
The study cohort included patients aged[18 years with
known or suspected CAD who underwent stress/rest gated-
SPECT imaging with either SD or DD protocol for clinical
indications in six institutions in Italy. At each site, patients
were retrospectively selected from the respective databases
according to the following inclusion criteria: stable sinus
rhythm and coronary angiography performed within 3 months
from the gated-SPECT. Patients were excluded if they had
pacemakers, previous coronary revascularization (CR) or
moderate-to-severe valvular disease. In each of the recruiting
institutions, a physician trained in nuclear cardiology collected
data on demographics, risk factors, and clinical presentation.
The type of stress (either exercise or pharmacological) was
based on the discretion of the physician performing the study.
The study protocol (SD or DD) and the radiopharmaceutical
used were according to the local practices at each site. An
informed written consent was obtained from all patients.
Gated-SPECT acquisition and interpretation
Stress and rest perfusion images were analyzed locally and
semi-quantitatively scored according to the 17-segmentmodel10
and a 5-point scale (from 0 = normal to 4 = absence of
detectable tracer uptake) with an automated software program
(QPS).10 The summed stress score (SSS) and summed rest score
(SRS)were calculated by adding the scores of the 17 segments in
the stress and rest images, respectively. SSS was classified as
follows:\4: Normal; 4–8: Mildly abnormal; 9–13: Moderately
abnormal;[13: Severely abnormal. The summed difference
score (SDS = SSS-SRS) was used as a marker of ischemia, and
classified as follows:\2:No ischemia; 2–4:Mild ischemia; 5–8:
Moderate ischemia;[8: Severe ischemia. Left ventricular
volumes and EF were measured after stress and at rest using a
previously validated software (QGS).11 The LVEF, end-systolic
volume (ESV), and end-diastolic volume (EDV) after stress and
at rest were calculated at each institution. Transient ischemic
dilatation was based on gated EDV and ESV.12
Coronary angiography was performed using standard
techniques;[50% luminal diameter narrowing was considered
significant stenosis.
Events during the follow-up were defined as the need for
percutaneous or surgical CR due to worsening symptoms or
hard events, defined as the occurrence of cardiac death or acute
coronary syndrome. These events were verified by review of
hospital records, interviewing patients, their family members
or treating physicians.
Statistical Analysis
Continuous data are presented as mean ± 1 standard
deviation. Categorical variables are presented as numbers or
proportions and were compared with the continuity corrected
Chi-square or Fischer’s-exact test, as appropriate. Patients
undergoing a SD or a DD protocol were balanced using the
propensity score matching procedure. Rosenbaum and Rubin
first proposed this method to balance the variables related to
the choice of the exposure (treatment) in order to reconstruct a
situation similar to a random assignment.13 The propensity
score model was generated using all potential covariates that
could affect the group allocation, in order to draw more
reliable results. A non-parsimonious logistic model was used to
estimate the individual probability to undergo a SD or a DD
study protocol for each patient. The matching procedure used
in this analysis was to match cases in the SD and DD group by
similarity of propensity score. A 1:1 matching procedure
without replacement was used. The impact of the study
protocol and amount of ischemia combinations on the LV
stress/rest EF changes was assessed by a two-way principal
analysis ANOVA. Two models were explored. In the first
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model, as independent variables (factors) were considered the
study protocol and amount of ischemia; in the second model,
the presence and extent of CAD were additional factors. The
LVEF changes were considered as the dependent variable in
all models. A post hoc test (Scheffe´ F test) was performed to
identify the main sources of variability. If a significant F value
was found for one independent variable, then this was referred
as a main effect. When a main effect was found, then a post
hoc test (Scheffe´ test) was performed to compare the depen-
dent variable upon the levels of the factor, thus identifying the
main sources of variability. A multinomial logistic regression
analysis was performed, to identify independent predictors of
Table 1. Characteristics of the study cohort
Tetro SD Mibi SD Mibi DD P
N 525 151 445
Age 64.5 ± 9.9 64.0 ± 9.5 66.6 ± 8.9 .001
Gender, M, n (%) 388 (73.9) 85 (56.2) 316 (71.1) .0002
Stressor, n (%): \.0001
Exercise 406 (77.3) 101 (66.9) 222 (49.9)
Dipyridamole 119 (22.7) 50 (33.1) 223 (50.1)
Coronary angiography, n (%) \.0001
No CAD 233 (44.4) 15 (9.9) 95 (21.3)
Single vessel disease 132 (25.1) 6 (4.0) 68 (15.3)
Multi-vessel disease 160 (30.5) 130 (86.1) 282 (63.4)
Coronary risk factors, n (%)
Hypertension 301 (57.3) 115 (76.1) 294 (66.1) \.001
Hypercholesterolemia 304 (57.9) 80 (52.9) 220 (49.4) .03
Diabetes mellitus 118 (22.5) 122 (80.8) 95 (21.3) \.001
Previous MI, n (%) 15 (2.9) 30 (19.9) 154 (34.6) \.0001
Delay injection-stress acquisition (min) 16.5 ± 5.0 28.6 ± 3.5 37.9 ± 8.2 All\.001
CAD coronary artery disease, %HR percentage of maximal age-predicted heart rate, MI myocardial infarction
Table 2. Clinical findings in the study cohort before and after propensity matching
Before Matching
P
After Matching
PTetro SD MIBI DD Tetro SD MIBI DD
N 525 445 245 245
Age 64.5 ± 9.9 66.6 ± 8.9 .007 66.0 ± 9.5 67.1 ± 8.6 .18
Gender, M, n (%) 388 (73.9) 316 (71.1) .31 192 (78.4) 179 (73.2) .11
Stressor, n (%): \.0001 .97
Exercise 406 (77.3) 222 (49.9) 142 (57.9) 143 (58.1)
Dipyridamole 119 (22.7) 223 (50.1) 103 (42.1) 102 (41.9)
Exercise %HR 83.2 ± 10.4 83.0 ± 10.5 0.25 81.2 ± 0.9 83.7 ± 10.0 .17
Coronary angiography, n (%) \.0001 .29
No CAD 233(44.4) 95 (21.3) 75 (30.6) 74 (30.1)
Single vessel disease 132 (25.1) 68 (15.3) 41 (16.8) 29 (11.9)
Multi-vessel disease 160 (30.5) 282 (63.4) 129 (52.6) 142 (58.0)
Coronary risk factors, n (%)
Hypertension 301 (57.3) 294 (66.1) \.006 160 (65.3) 159 (65.1) .95
Hypercholesterolemia 304 (57.9) 220 (49.4) .01 143 (58.4) 122(50.0) .09
Diabetes mellitus 118 (22.5) 95 (21.3) .57 47 (19.2) 42 (17.1) .54
Previous MI, n (%) 15 (2.9) 154 (34.6) \.0001 15 (6.1) 20 (8.1) .48
Delay injection-stress acquisition (min) 16.5 ± 5 37.9 ± 8.2 \.001 17.0 ± 6.0 37.5 ± 7.5 \.001
CAD coronary artery disease, %HR percentage of maximal age-predicted heart rate, MI myocardial infarction
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events, considering the occurrence of hard events or CR as
dependent variables, with patients with ‘‘no events’’ as
reference group. The v2 value, odds ratio (OR), corresponding
95% confidence interval (CI), and the Wald test P value are
reported for each factor. Survival estimates for patients
grouped according to the study protocol were calculated using
the Kaplan–Meier method and compared by the log-rank test.
To assess the incremental prognostic information from the
addition of demographic, clinical, scintigraphic, and angio-
graphic variables, data analysis was also performed according
to a modified stepwise procedure in which individual factors
were included in the model in the same order in which they
would be considered in the clinical practice. Increment in
information of the model at each step was considered signif-
icant when the log-likelihood difference had a P value\0.05.
Statistical analysis was performed with Statistical Version 10
(StatSoft, Tulsa, USA. Propensity matching was performed
with the MatchIt Package14 for R (version 3.1.1).15 A P
value\0.05 (two-tailed) was considered significant.
RESULTS
The study cohort included 1121 patients with a
mean age 65.1 + 9.6 years, of whom 70% were men.
The SD stress/rest protocol was employed in 676 (60%)
patients and the DD protocol in 445 (40%); 99mTc-
tetrofosmin was used in 525 (47%) patients and 99mTc-
sestamibi in 596 (53%). The tracer-protocol combina-
tions employed as well as the respective pertinent
clinical data are shown in Table 1. Tetrofosmin was
exclusively used in conjunction with the SD protocol,
while 75% of studies with sestamibi employed the DD
protocol. The choice of the pharmaceutical was based on
local practices and not upon patient demographics.
Patients undergoing the SD protocol were younger,
mostly males, very few had a prior myocardial infarction
and the majority were able to perform an exercise stress
test. A multi-vessel disease was documented in 86% of
Table 3. Perfusion and function data in matched groups according to the type of protocol
Perfusion data Tetro SD Mibi DD P
N 245 245
SRS 2.2 ± 3.9 2.2 ± 4.5 .94
SSS 7.0 ± 5.0 6.5 ± 6.4 .26
SDS 4.9 ± 3.2 4.2 ± 4.2 .08
% Abnormal myocardium rest 3.2 ± 5.7 3.2 ± 6.6 .94
% Abnormal myocardium stress 10.4 ± 7.3 9.5 ± 9.4 .24
% Abnormal myocardium ischemic 7.1 ± 4.7 6.2 ± 6.2 .08
SSS category, n (%)
Normal 0–3 53 (21.6) 75 (30.5) \.0001
Mild 4–8 120 (49.0) 69 (28.0)
Moderate 9–13 44 (18.0) 33 (13.4)
Severe[13 28 (11.4) 69 (28.1)
SDS category, n (%)
No ischemia 0–1 36 (14.7) 87 (35.4) \.0001
Mild ischemia 2–3 82 (33.5) 56 (22.8)
Moderate ischemia 4–7 96 (39.2) 65 (26.4)
Severe ischemia[8 31 (12.6) 38 (15.4)
Functional data
LVEF rest (%) 53.8 ± 13.8 54.4 ± 14.1 .61
LVEF stress (%) 51.6 ± 13.9 51.8 ± 14.0 .88
stress/rest LVEF changes -2.2 ± 4.9 -2.6 ± 6.7 .39
EDV index stress (cc/m2) 65 ± 29 55 ± 24 \.001
ESV index stress (cc/m2) 34 ± 25 29 ± 21 .02
EDV index rest (cc/m2) 62 ± 28 54 ± 22 \.001
ESV index rest (cc/m2) 32 ± 26 27 ± 19 .01
TID EDV 1.04 ± 0.1 1.05 ± 0.15 .43
TID ESV 1.10 ± 0.22 1.13 ± 0.28 .20
% Abnormal myocardium (stress and rest) was calculated by dividing the summed scores by 68, the maximum potential score (4
points 9 17 segments), and multiplying by 100. The difference (stress-rest) indicates the % Abnormal Myocardium Ischemic
EDV end-diastolic volume, EF Ejection fraction, ESV end-systolic volume, LV left ventricle, SDS summed difference score, SRS
summed rest score, SSS summed stress score, TID transient ischemic dilation
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patients undergoing the SD protocol with sestamibi,
while 44% of patients undergoing the SD tetrofosmin
protocol had no significant CAD.
To avoid the influence of confounders on the
analysis of the relation between the different study
protocols, a propensity matching approach was used,
with the exclusion of the group of patients undergoing
the SD protocol with sestamibi, due to the smaller
sample size (n = 151; Table 1). Clinical and angio-
graphic data before and after matching are reported in
Table 2. Though no significant differences were docu-
mented between the SD and the DD protocol in SSS,
SRS, and SDS, patients undergoing the DD protocol
more frequently showed either normal or severely
abnormal results than patients undergoing the SD
protocol (Table 3). No significant differences were
documented between the two groups regarding rest
and post-stress LVEF. However, stress and rest LV end-
diastolic and end-systolic volumes were significantly
higher in patients undergoing the SD protocol (Table 3).
Combined perfusion and function
assessment
To better define the relative influence of the study
protocol and the amount of ischemia on stress/rest LVEF
changes, a two-way ANOVA was performed. In the first
model, the amount of ischemia (F = 6.02; P\ .001)
and the study protocol (F = 4.2; P = .041) had a
significant impact on the change in EF (stress test) while
the type of stress was not (F = 0.04, P = NS). The
LVEF and the change in EF varied according to the
presence and severity of ischemia in the SD and DD
protocols (Figure 1). Post hoc evaluation of the relative
effect of the study protocol and the presence and
severity of ischemia showed no significant differences in
the group of patients who underwent the SD protocol;
however, a significantly greater reduction in the LVEF
was documented in patients with severe ischemia
undergoing the DD protocol (Figure 2).
In the second model, including also extent and
severity of CAD, the extent of ischemia remained to
have a significant impact on the change in LVEF
(F = 5.0, P = 0.002), while the presence (F = 1.10,
Figure 1. Schematic representation of the single-day (SD) and
dual-day (DD) protocols, with associated test and acquisition
average timings. Left ventricular ejection fraction values and
stress/rest ejection fraction changes (DEF) are reported,
according to the presence and severity of ischemia.
Figure 2. Graph showing the stress/rest left ventricular ejec-
tion fraction changes (DEF) according to the amount of
ischemia in relation to the study protocol employed. Vertical
bars denote 95% Confidence Intervals. DD Dual-day, SD
Single-day.
Figure 3. Graph showing the stress/rest left ventricular ejec-
tion fraction changes (DEF) according to the amount of
ischemia in relation to the study protocol employed and to the
severity of coronary artery disease. Vertical bars denote 95%
Confidence Intervals. DD Dual-day, MVD Multiple-vessel
disease; SD Single-day.
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P = 0.29) and severity of CAD (F = 0.24, P = 0.62)
and the study protocol (F = 2.85, P = 0.09) were not
(Figure 3).
The post-stress and rest LV volumes according to
presence and severity of ischemia and the study
protocol employed are reported in Table 4. Left ven-
tricular volumes (EDV and ESV) increase with the
worsening of ischemia both in the SD and DD protocol.
Across the different amounts of ischemia, LV volumes
are higher for the SD than for the DD protocol, both at
rest and after stress. According to the two-way
ANOVA, while the amount of ischemia is responsible
for the increase in volumes (with the same trend in SD
and DD), only the study protocol is the factor signif-
icantly associated to the differences in LV volumes
within the same category of severity of ischemia, both
post-stress and at rest.
Outcome data
During an average follow-up of 3.2 ± 2.1 years
(range 8 days to 5.2 years) 240 patients (49.0% of the
propensity matched patients) underwent CR and 52
patients (10.6%) had hard events. A comparable cumu-
lative event rate was documented in the SD (55.3%) and
in the DD (63.9%) groups (P = 0.08) (Figure 4).
Clinical and MPI data in those with and without
events are shown in Table 5. Those with events were
older, more likely men, have diabetes mellitus and
multi-vessel CAD. Patients with hard events had higher
SSS, EDV, and ESV, and lower rest and post-stress
LVEF than patients with no events or undergoing CR
(Table 5). Patients with undergoing CR had greater SDS
and stress/rest LVEF changes than patients with no
events (Table 5).
When the clinical and MPI variables that were
significantly associated with events by univariate anal-
ysis were included in a multiple logistic regression
analysis, the presence of multi-vessel CAD was the
strongest variable associated with both hard events and
CR (Table 6). Amongst the MPI variables, the SDS was
independently associated with both CR and hard events,
and the post-stress EF was associated with CR. The
change in EF between post-stress and rest was not
independently associated with either CR or hard events.
When clinical, perfusional and functional scintigraphic
data, and CAD extent were sequentially added in a
stepwise model, gated-SPECT data had a significant
incremental prognostic value for CR and hard events
Table 4. Left ventricular rest and post-stress end-systolic and end-diastolic volumes according to the
study protocol
Tetro SD MIBI DD Tetro SD MIBI DD
EDV rest (F 5 13.7, <0.001) EDV post-stress (F 5 12.1, <0.001)
No ischemia 117 ± 37 89 ± 46 117 ± 38 92 ± 48
Mild 119 ± 41 105 ± 59 122 ± 43 106 ± 59
Moderate 112 ± 36 100 ± 36 118 ± 39 105 ± 38
Severe 130 ± 62 110 ± 45 135 ± 64 119 ± 46
ESV rest (F 5 7.3, =0.007) ESV post-stress (F 5 5.5, =0.019)
No ischemia 59 ± 33 45 ± 38 63 ± 56 47 ± 41
Mild 61 ± 32 55 ± 48 65 ± 53 57 ± 51
Moderate 60 ± 29 48 ± 28 63 ± 41 55 ± 33
Severe 74 ± 54 54 ± 36 99 ± 48 67 ± 39
Abbreviations as Table 3
Volumes are in ml
F values related to the study protocols as main effect
Figure 4. Kaplan-Meier survival estimates for patients
grouped according to the study protocol.
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over clinical variables; the addition of CAD information
further improved the global v2 regarding CR but not for
hard events (Figure 5).
DISCUSSION
This study evaluated the differential effects of 2
study protocols on the changes in LVEF (between post-
stress and rest) and myocardial perfusion by gated-
SPECT MPI using a propensity matching model in a
large cohort of patients in whom the coronary anatomy
was also defined by invasive coronary angiography.
Severe ischemia were higher in patients undergoing the
DD protocol, independently of the extent of CAD. The type
of stressor employed did not seem to influence the relation-
ship between the amount of ischemia and LVEF changes.
Differences in the time interval between the stress
tracer injection and image acquisition, and between
Table 5. Clinical and scintigraphic data according to the presence and type of events at follow-up
No Events Hard Events Revasc P value
N (%) 198 (40.4) 52 (10.7) 240 (49)
Age (years) 64.4 ± 9.4 70.7 ± 8.5*$ 66.7 ± 8.8 * vs Revasc;
$ vs No events
Gender, M, n (%) 131 (66.1) 40 (76.1) 191 (79.6) 0.01
Study protocol §, n (%) 0.18
Single-day 109 (44.6) 23 (9.3) 113 (46.1)
Dual-day 89 (36.1) 29 (12.0) 127 (51.8)
Clinical findings, n (%)
Previous MI 14 (6.9) 4 (8.1) 0 0.14
Multi-vessel disease 56 (28.2) 31 (69.6) 151 (63.0) \0.0001
Risk factors, n (%)
Hypertension 128 (64.4) 37 (71.7) 149 (62.1) 0.46
Diabetes mellitus 38 (14.9) 20 (39.1) 44 (18.5) =0.001
Hypercholesterolemia 98 (49.4) 20 (39.1) 144 (60.2) =0.01
Stressor, n (%) =0.001
Exercise 94 (47.7) 26 (50.0) 158 (65.9)
Dipyridamole 104 (52.3) 26 (50.0) 82 (34.1)
Scintigraphic data
SSS 5.9 ± 5.9 9.1 ± 6.1#* 7.6 ± 5.4$ #, $ vs no events;
* vs Revasc.
SDS 3.4 ± 3.2* 5.4 ± 3.9 5.8 ± 3.9 * vs hard events and Revasc
Rest LVEF (%) 52.3 ± 14.7 46.1 ± 16.9$* 56.0 ± 11.1 $ vs Revasc;
* vs No events.
Post-stress LVEF (%) 50.5 ± 14.7 44.2 ± 17.2$* 52.6 ± 11.7 $ vs Revasc;
* vs No events.
Stress/rest LVEF changes -1.8 ± 5.6 -1.9 ± 5.5 -3.4 ± 6.3* * vs Hard events and No events
Rest EDV (ml) 116 ± 63 122 ± 58$ 101 ± 37* $ vs Revasc;
* vs No events.
Rest ESV (ml) 62 ± 54 73 ± 56$* 47 ± 29* $ vs Revasc;
* vs No events
Post-stress EDV (ml) 120 ± 65 125 ± 59$* 106 ± 40* $ vs Revasc;
* vs No events.
Post-stress ESV (ml) 67 ± 57 78 ± 58$* 54 ± 33 $ vs Revasc;
* vs No events.
§ Proportion of events according to the study protocol
Revasc: Revascularization. Other abbreviations as Table 3
For continuous variable, the ‘‘between groups’’ comparisons from ANOVA is shown. For categorical variables, the global Chi-
square p value is reported
* P\0.05; $ P\0.01; # P\0.001
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stress and rest evaluation, might provide partial expla-
nation to the observed data. In our study, the post-stress
LVEF in the SD and the DD was comparable across all
degrees of ischemia, despite the average time-interval
between the stress test and images acquisition were
shorter in the SD than in the DD (16 vs 38 min).
However, rest LVEF in patients with severe ischemia in
the DD group was higher than in the SD group, thus
explaining the differences in the change in EF. The
delay between the stress and rest imaging in the SD
might be too short to ensure a complete functional
recovery in patients with severe ischemia.
Despite these differences, all MPI variables were
significantly associated with the events by univariate
analysis; however, by logistic multinomial regression
analysis, the post-stress EF and the SDS were indepen-
dently associate with events, in both the SD or DD
protocol. After correction for confounders, the change in
EF was not independently predictive of the occurrence
of events.
Clinical Implications
In the last decades, perfusion and function infor-
mation obtained from stress/rest gated-SPECT MPI has
provided powerful diagnostic and prognostic tool and
has assumed a central role in the management of patients
with known or suspected CAD.1,2,4,5 Post-stress LVEF
and end-systolic volumes have incremental prognostic
value over perfusion data.16 The change in LVEF has
been considered as a marker of stunning and large
ischemia and has providing additional diagnostic and
prognostic information.17–19
The delay between stress tracer injection and
images acquisition has been documented to influence
the severity of stress induced perfusion defects.20–22
Table 6. Multinomial logistic regression analysis results, assessing independent factors predisposing
to hard events or revascularization during follow-up; patients with no events are the reference group
v2 Wald test P value OR 95% CI
Outcome: hard events
Variable
Multi-vessel disease (y) 12.7 0.0004 4.45 1.93–10.12
Age* 10.8 0.001 1.08 1.03–1.14
Diabetes mellitus (y) 8.6 0.003 3.40 1.49–7.70
Summed difference score* 4.42 0.035 1.14 1.01–1.29
Outcome: revascularization
Variable
Multi-vessel disease (y) 17.9 \0.0001 2.92 1.78–4.81
Summed difference score* 16.82 \0.0001 1.23 1.11–1.35
Age (y)* 6.2 0.013 1.03 1.01–1.06
Gender, M 5.5 0.018 2.02 1.12–3.64
End–systolic volume* 5.4 0.021 0.987 0.975–0.998
Post-stress LV ejection fraction* 4.14 0.04 1.02 1.01–1.05
* As continuous variable
y yes
Figure 5. Bar graph illustrating the incremental prognostic
value (depicted by the global v2 values on the y-axis) of
perfusional (Summed Stress Scores, SSS, and Summed
Difference Scores, SDS) and functional (Stress LVEF and
Stress/Rest LVEF) over clinical data for coronary revscular-
ization (CR) and hard events. The presence of significant
coronary stenoses has a further significant incremental prog-
nostic for CR, but not for hard events. CAD coronary artery
disease; LVEF left ventricular ejection fraction; MI myocardial
infarction.
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Moreover, LV volume and EF values were also influ-
enced by the delay from tracer injection to images
acquisition, when correlated to the amount of ische-
mia.23 In the study by Mut et al in the SD protocol group
the rest evaluation was performed first, thus the possible
effect of a prolonged stunning also affecting rest
evaluation was not an issue.23 In conventional SD
protocol, however, stress study is usually performed
first, to allow for the possibility of a stress-only
approach in the case of normal perfusion and function,
thus requiring one tracer injection only. In our study,
rest study in the SD protocol was performed on average
3 h after stress study and the possibility of a prolonged
stunning in patients with severe ischemia, affecting rest
LVEF, may explain the underestimation of the change in
LVEF when compared to the DD protocol.21 Our results
are in agreement with those previously obtained in 1089
patients from a subgroup analysis of the J-ACCESS
study, were a drop in LVEF greater than 5% did not
predict events.19 The selection of a SD or a DD protocol
is related to local logistics and patients preferences;
however, in terms of patients’ and operators’ radiation
exposition, the SD protocol, requiring a 3:1 activity ratio
between rest and stress studies6 seems unfavorable
compared to the DD approach.
Limitations
The analysis and interpretation of gated-SPECT
images were not centralized; however, this reflects a
real-world snapshot, and the same approach was used in
other multi-center studies.19,24
Randomized clinical trials are considered the gold
standard in clinical evaluations. When properly
conducted, randomization ensures that groups are com-
parable; consequently, any difference detected is attri-
butable to the intervention. Non-randomized data from
observational studies can then be an alternative to
randomized clinical trials, as they allow measuring the
real-life practice and potentially producing more gener-
alizable results. Unlike randomization, propensity
matching could only remove overt (known) biases, but
hidden biases cannot be excluded. As mentioned before
the SD and DD protocols used different tracers which
potentially could also be a confounder for the variability.
Finally, since the group of patients undergoing ses-
tamibi SD protocol was not included in the matching
procedure, we are not able tomake inference on the possible
lack of differences between sestamibi SD or DD protocol.
CONCLUSIONS
In patients with severe ischemia, a possible under-
estimation of myocardial stunning could be observed
with the SD protocol, in comparison to a propensity
matched group of patients undergoing the DD protocol.
The stressor employed and the severity of the underlying
CAD do not seem to influence these results.
After correction for confounders, post-stress LVEF
and the amount of ischemia, but not the change in EF,
were the scintigraphic predictors of events; SD and DD
protocols come out of equal value in predicting the
occurrence of clinical events.
NEW KNOWLEDGE GAINED
Post-stress left ventricular ejection fraction and the
amount of ischemia, obtained either with a SD or DD
gated-SPECT protocol, provide comparable prognostic
information. The change in EF (stress-rest) was not
independent predictors of events. The change in EF is
less in severe ischemia with SD than DD protocol.
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